Bioteque - Asset Resilience Ratio
Bioteque (4107) has an Asset Resilience Ratio of 10.88% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2025)
This chart shows how Bioteque's Asset Resilience Ratio has changed over time. Check how strategically is Bioteque's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Bioteque's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4107 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$506.88 Million | 10.88% |
| Total Liquid Assets | NT$506.88 Million | 10.88% |
Asset Resilience Insights
- Moderate Liquidity: Bioteque has 10.88% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Bioteque Industry Peers by Asset Resilience Ratio
Compare Bioteque's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.46% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for Bioteque (2006–2025)
The table below shows the annual Asset Resilience Ratio data for Bioteque.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 10.88% | NT$506.88 Million ≈ $15.97 Million |
NT$4.66 Billion ≈ $146.82 Million |
+3.13pp |
| 2024-12-31 | 7.75% | NT$360.09 Million ≈ $11.34 Million |
NT$4.65 Billion ≈ $146.36 Million |
+3.19pp |
| 2023-12-31 | 4.56% | NT$210.72 Million ≈ $6.64 Million |
NT$4.62 Billion ≈ $145.57 Million |
-1.02pp |
| 2022-12-31 | 5.59% | NT$250.26 Million ≈ $7.88 Million |
NT$4.48 Billion ≈ $141.16 Million |
-5.80pp |
| 2021-12-31 | 11.38% | NT$439.50 Million ≈ $13.85 Million |
NT$3.86 Billion ≈ $121.64 Million |
+3.17pp |
| 2020-12-31 | 8.21% | NT$292.60 Million ≈ $9.22 Million |
NT$3.56 Billion ≈ $112.28 Million |
+2.14pp |
| 2019-12-31 | 6.07% | NT$178.63 Million ≈ $5.63 Million |
NT$2.94 Billion ≈ $92.64 Million |
-0.36pp |
| 2018-12-31 | 6.43% | NT$178.27 Million ≈ $5.62 Million |
NT$2.77 Billion ≈ $87.32 Million |
-0.24pp |
| 2017-12-31 | 6.67% | NT$174.98 Million ≈ $5.51 Million |
NT$2.62 Billion ≈ $82.59 Million |
-0.61pp |
| 2016-12-31 | 7.28% | NT$186.68 Million ≈ $5.88 Million |
NT$2.56 Billion ≈ $80.77 Million |
-0.15pp |
| 2015-12-31 | 7.43% | NT$186.15 Million ≈ $5.86 Million |
NT$2.50 Billion ≈ $78.88 Million |
-0.29pp |
| 2014-12-31 | 7.73% | NT$181.38 Million ≈ $5.71 Million |
NT$2.35 Billion ≈ $73.94 Million |
-2.32pp |
| 2013-12-31 | 10.05% | NT$200.75 Million ≈ $6.32 Million |
NT$2.00 Billion ≈ $62.92 Million |
-10.05pp |
| 2012-12-31 | 20.10% | NT$326.94 Million ≈ $10.30 Million |
NT$1.63 Billion ≈ $51.24 Million |
+2.24pp |
| 2011-12-31 | 17.86% | NT$290.81 Million ≈ $9.16 Million |
NT$1.63 Billion ≈ $51.30 Million |
-3.12pp |
| 2010-12-31 | 20.98% | NT$353.44 Million ≈ $11.14 Million |
NT$1.69 Billion ≈ $53.09 Million |
+1.12pp |
| 2009-12-31 | 19.85% | NT$342.91 Million ≈ $10.80 Million |
NT$1.73 Billion ≈ $54.41 Million |
-0.12pp |
| 2008-12-31 | 19.98% | NT$343.94 Million ≈ $10.84 Million |
NT$1.72 Billion ≈ $54.25 Million |
+6.61pp |
| 2007-12-31 | 13.37% | NT$220.71 Million ≈ $6.95 Million |
NT$1.65 Billion ≈ $52.02 Million |
-3.29pp |
| 2006-12-31 | 16.66% | NT$218.09 Million ≈ $6.87 Million |
NT$1.31 Billion ≈ $41.25 Million |
-- |
About Bioteque
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter… Read more